Trending stocks today
Royalty Pharma plc
Comcast Corp
Onity Group. Inc.
Allstate
CVS Health Corp
Savaria Corp
Jamieson Wellness
Stella-Jones Inc.
Tesla Inc
CVS Health Corp
Advanced Micro Devices
Broadcom
Mastercard Inc.
Superior Plus Corp
Omnicom Group
GlaxoSmithKline PLC
Leidos Holdings, Inc.
Africa Oil Corp.
International Petroleum Company
Ecora Resources
Centric Health (CHH-T)
NEW AI Investor Insights
99 watching
TSE:CHH
0.23
0.00
(0.00%) 1d
Financials
Technical Analysis
Jun 24, 2020, 8:00 pm
0
Related posts
Top 4 Canadian Healthcare Stocks Catapult by the Worldwide Aging DemographicStocks slump but oil continues to rise23 Stock Top Picks and 7 ETF (Nov 30 Dec 6)
WATCH
It is an interesting business. It is specialty pharmacies. They do medication for long term care facilities. They have an interesting pouch technology. They had quite a significant debt load and made a big dent in it when they sold their surgical business. They are trying to pick up new contracts. He has owned it in the past and is watching it now to see how they execute.
other services
$0.225
No
TOP PICK
They made huge strides in the past year. They are Canada's biggest provider of meds to seniors' homes. Stock has risen over 50% during the pandemic, partially because they just completed a highly accretive purchase of another company. They have a strong balance sheet now, so they can continue to consolidate in a fragmented industry. The only other big player is Shoppers Drug Mart. CHH has a good balance sheet. Contracts with these retirement homes are coming for renewal in the coming 12 months. This stock could double in 12 months. He expects organic and acquisition growth. (Analysts’ price target is $0.38)
other services
TOP PICK
One of the biggest suppliers of meds to Canadian seniors' care facilities, so they're having their day in the sun now. Seniors need their meds. In March they made an accretive acquisition that'll make them then #1 player in Canada. A strong balance sheet plus great organic growth from contracts to be renewed later this year. The stock is still cheap and could double in 12 months. A safe play. Little uncertainty in their business. (Analysts’ price target is $0.35)
other services
TOP PICK
It is a good demographic play. They really cleaned up their act and hired a new CEO. They cleaned up their balance sheet. They are in a good position to make acquisitions to consolidate the space. (Analysts’ price target is $0.20)
other services
WATCH
They had a challenging last couple of years. They got over levered. They sold their surgical business. Now you are starting to see them accelerate the pharmacy business. They have less than 10% of the beds in long term care facilities in Canada. They also have a new product to control seniors taking the right medication at the right time. He is waiting to see acceleration in their earnings.
other services
PAST TOP PICK
(A Top Pick Dec 03/18, Down 56%) One of Canada's largest distributors of medications to senior's residences, retirement homes and long term care facilities. They divested themselves of surgery clinics. They got a much lower price than the market was anticipating and so have less cash to pay down debt. The core business, however, had excellent results and continues to improve. They announced a financing and he is going to vote in favour of it. It will give them the ability to grow the core business, which is fragmented across Canada. An easy double or triple over the next few years.
other services
PAST TOP PICK
(A Top Pick Sep 24/18, Down 68%) He still likes it. It's the biggest specialty pharma distributor of meds to seniors residences in Canada. The stock got hammered recently, because they didn't get the price the market expected for selling the surgery clinics (the deal closes Sept. 30). Still, they will pay down a lot of debt with this deal. The new CEO has done a fantastic job by cutting costs and increasing gross margins, but the market is ignoring this. Their EBITDA is growing. When the sale closes, he'll buy more stock.
other services
DON'T BUY
It is not a good entry point. They got hit when governments were not reimbursing as much for prescriptions. They seem to have stabilized that. He is nervous about it.
other services
HOLD
He is waiting for a catalyst. They are trying to sell their surgery clinics in Ontario and BC. As soon as that is announced they can pay down a huge amount of debt. The new CEO is really good and there is real potential to grow the business going forward.
other services
COMMENT
A disappointment. The stock has fallen a lot. They are selling off their western surgical division which should pay off a lot of their debt. They recently added a home-delivery system of pills to seniors, which may be revolutionary. CHH has signed up to be an exclusive provider of cannabis to seniors care facilities--and this could be profitable.
other services
PAST TOP PICK
(A Top Pick Apr 11/18, Down 42%) It has been very disappointing. He was hoping they would see quite a few catalysts which didn't materialize. They signed a deal making them an exclusive distributor of cannabis into nursing homes. When we have alternative delivery systems, this will probably accelerate.
other services
BUY
It will be the turnaround story for 2019. They are cutting costs in the pharma business. They have these surgery clinics that are up for sale. The market is speculating that they will get a really good price for them. They will pay down most of their debt. They may become more of a takeover target in a couple of years.
other services
DON'T BUY
Overall the health care sector is a good one. EPS are expected to be $0.01 in 2019 -- making the company basically break-even. They also provide bulk purchases in a pharmacy setting with a technology application for each customer. They plan to expand into Quebec. It is not a stock to be buying just yet.
other services
BUY
There could be a number of metrics coming in their favor soon. They have been trying to sell off their surgical division, which would allow for growth in other areas. They dispense a lot of pharma into nursing homes. They have some exclusive agreements with cannabis suppliers into these facilities. They have a home dispensing products for pills that he thinks will be very positive.
other services
TOP PICK
One of Canada's largest distributors of medication to seniors' residences. They will announce they are selling non-core assets. They will get to pay down pretty much all their debt. He really expects this stock to move up rapidly – a double to a triple over the next year. This is an industry that is growing. (Analysts’ price target is $0.65)
other services
Centric Health(CHH-T) Rating
Ranking : 1 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 0
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 0
Centric Health(CHH-T) Frequently Asked Questions
What is Centric Health stock symbol?
Centric Health is a Canadian stock, trading under the symbol CHH-T on the Toronto Stock Exchange (CHH-CT). It is usually referred to as TSX:CHH or CHH-T
Is Centric Health a buy or a sell?
In the last year, there was no coverage of Centric Health published on Stockchase.
Is Centric Health a good investment or a top pick?
Centric Health was recommended as a Top Pick by on . Read the latest stock experts ratings for Centric Health.
Why is Centric Health stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Centric Health worth watching?
0 stock analysts on Stockchase covered Centric Health In the last year. It is a trending stock that is worth watching.
What is Centric Health stock price?
On 2020-06-24, Centric Health (CHH-T) stock closed at a price of $0.225.
Advertising
